Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis: a growing epidemic.

I Fogelman1, P Ryan

  • 1Division of Radiological Sciences, Guy's Hospital, London.

The British Journal of Clinical Practice
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies.

The journal of prevention of Alzheimer's disease·2017
Same author

Correction to: 18F-NaF PET/CT: EANM procedure guidelines for bone imaging.

European journal of nuclear medicine and molecular imaging·2017
Same author

Changes in bone mineral density and bone turnover in patients on 'drug holiday' following bisphosphonate therapy: real-life clinic setting.

Clinical endocrinology·2015
Same author

Circulating concentrations of vitamin E isomers: Association with bone turnover and arterial stiffness in post-menopausal women.

Bone·2015
Same author

(18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.

European journal of nuclear medicine and molecular imaging·2015
Same author

The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.

Cytokine·2014

Preventing osteoporosis is crucial, especially for women post-menopause. Measuring bone density allows for early intervention with hormone replacement therapy (HRT) or future non-hormonal treatments to mitigate fracture risk.

Area of Science:

  • Gerontology
  • Endocrinology
  • Public Health

Background:

  • Osteoporosis poses a significant public health challenge, with an ongoing epidemic.
  • Women experience accelerated bone loss after menopause, increasing fracture risk.
  • Low bone density at menopause is a key predictor of future fractures.

Purpose of the Study:

  • To highlight the urgency of addressing osteoporosis prevention.
  • To identify the optimal time for intervention in women.
  • To discuss current and potential strategies for preventing bone loss.

Main Methods:

  • Review of current understanding of osteoporosis and menopausal bone loss.
  • Emphasis on bone density measurement for risk assessment.
  • Discussion of therapeutic interventions, including hormone replacement therapy (HRT).

Related Experiment Videos

Main Results:

  • Bone loss accelerates post-menopause, making it a critical intervention window.
  • Accurate bone density measurement identifies high-risk individuals.
  • Hormone replacement therapy (HRT) is currently the primary long-term prevention strategy.

Conclusions:

  • Proactive prevention of bone loss is essential to combat the osteoporosis epidemic.
  • Targeted intervention in women at menopause, based on bone density, is recommended.
  • While HRT is the current mainstay, promising non-hormonal agents are anticipated.